Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin vs Rosiglitazone in Dysmetabolic Dyslipidemia
NCT00304993Phase 4Completed
- Start
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of niacin, rosiglitazone in metabolic syndrome, dyslipidemia. Started Jan 2001; status: completed.
02
Drugs
niacinrosiglitazone
03
Conditions
metabolic syndromedyslipidemia
Beyond the preview
Go deeper on NCT00304993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304993.